Showing posts with label Roth Capital. Show all posts
Showing posts with label Roth Capital. Show all posts

Thursday, February 2, 2012

Virtusa (VRTU) (VRTX) (HSFT) (CEVA) (CIT) (ALV) Ratings, Price Targets

Virtusa Co. (NASDAQ: VRTU), Vertex Pharmaceuticals (NASDAQ: VRTX), HiSoft Technology International Limited (NASDAQ: HSFT), Ceva (NASDAQ: CEVA), CIT Group Inc. (NYSE: CIT) and AUTOLIV (NYSE: ALV) ratings and price targets.

Virtusa Co. (VRTU) had its “Buy” rating reiterated by Needham & Company.

Vertex Pharmaceuticals (VRTX) had its “Hold” rating reiterated by Brean Murray Carret & Co..

Roth Capital initiated coverage on HiSoft Technology International Limited (HSFT). They placed a “Buy” rating on the company.

Ceva (CEVA) had its price target lowered by Wunderlich from $38.00 to $36.00. They have a “Buy” rating on the company.

CIT Group Inc. (CIT) had its price target raised by Jefferies Group (NYSE:JEF) to $38.00.

AUTOLIV (ALV) was downgraded by Sidoti from a “Buy” rating to a “Neutral” rating.